Polynovo (PNV.AX) Trading Update
- Closing Price (23 Oct 2026): AUD 0.88
- Day’s Change: Down 0.56 %
- Market Capitalisation: AUD 420.3 million
- Shares Outstanding: 690.8 million
- Volume (last 24 h): AUD 681.7 k worth traded
- Year‑to‑Date Performance: Down 7.73 % since the previous month’s end
- 200‑Day Simple Moving Average: AUD 0.99
- 52‑Week High: AUD 1.42 (29 Oct 2025)
- 52‑Week Low: AUD 0.81 (28 Jul 2026)
Related Stocks – 24‑Hour Performance
| Symbol | Current Price | % Change | Market Capitalisation | P/E Ratio |
|---|---|---|---|---|
| Iperionx (IPX.AX) | AUD 1.78 | –2.60 % | AUD 470.1 million | – |
| Australian Ethical Invt (AEF.AX) | AUD 4.18 | –1.88 % | AUD 484.9 million | 18.89 |
| Aeris (AIS.AX) | AUD 0.40 | –7.53 % | AUD 471.7 million | 3.08 |
| Sks (SKS.AX) | AUD 5.65 | –4.25 % | AUD 477.5 million | 26.25 |
| Amotiv (AOV.AX) | AUD 5.63 | +0.36 % | AUD 500.3 million | 10.02 |
Company Profile
PolyNovo Ltd. is an Australian biotechnology firm headquartered in Port Melbourne. The company develops biodegradable polymers intended for use in various medical applications. It is publicly listed on the ASX All Markets and can be accessed for more information at www.polynovo.com .
